Page 1 of Clinical Trials for ( Ortho Biotech Products AND L.P. ) [SPONSOR-COLLABORATORS], 51 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)
Last Updated: May 17, 2011
Condition(s): Anemia; HIV Infections
2
Completed
A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)
Last Updated: May 17, 2011
Condition(s): Anemia; Chronic Renal Insufficiency
3
Completed
NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection
Last Updated: May 17, 2011
Condition(s): Hepatitis C; HIV; Anemia
4
Withdrawn
Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis
Last Updated: July 21, 2011
Condition(s): Anemia; Rheumatoid Arthritis
5
Completed
A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)
Last Updated: May 17, 2011
Condition(s): Hepatitis C; Anemia
6
Enrolling by invitation
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies (D.O.S.E. Registry)
Last Updated: February 27, 2009
Condition(s): Epoetin Alfa; Cancer; Anemia; Darbepoetin Alfa
7
Terminated
A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.
Last Updated: May 17, 2011
Condition(s): Anemia; Chronic Renal Insufficiency
8
Terminated
A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)
Last Updated: May 17, 2011
Condition(s): Anemia; Kidney Diseases
9
Completed
A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy
Last Updated: May 19, 2011
Condition(s): Anemia; Hodgkin Disease; Leukemia; Lymphoma, Non-hodgkin
10
Completed
Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia
Last Updated: May 17, 2011
Condition(s): Anemia; Chemotherapy
11
Terminated
A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.
Last Updated: May 17, 2011
Condition(s): Anemia; Neoplasms
12
Terminated
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer
Last Updated: May 17, 2011
Condition(s): Anemia; Breast Neoplasms; Hemoglobins; Quality of Life; Chemotherapy, Adjuvant
13
Terminated
RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia
Last Updated: July 2, 2007
Condition(s): Chemotherapy; Cancer; Anemia
14
Completed
Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery
Last Updated: June 8, 2011
Condition(s): Stomach Neoplasms; Rectal Neoplasms
15
Completed
Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy
Last Updated: June 8, 2011
Condition(s): Anemia
16
Terminated
PROCRIT and Short-Term Outcomes in Orthopedic Surgery
Last Updated: June 8, 2011
Condition(s): Anemia; Surgery, Arthroscopy
17
Recruiting
A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.
Last Updated: September 25, 2006
Condition(s): Diffuse Large B Cell Lymphoma; Lymphoma, Non-Hodgkin
18
Completed
An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks
Last Updated: June 8, 2011
Condition(s): Cancer; Anemia
19
Terminated
Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
Last Updated: April 2, 2009
Condition(s): Contrast Induced Nephropathy
20
Terminated
Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
Last Updated: February 20, 2012
Condition(s): Anemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Ortho+Biotech+Products%2C+L.P.

Page 1 of Clinical Trials for ( Ortho Biotech Products AND L.P. ) [SPONSOR-COLLABORATORS], 51 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About